We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-14.56%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$688M
AUM Growth
-$52M
Cap. Flow
-$219M
Cap. Flow %
-31.89%
Top 10 Hldgs %
65.57%
Holding
231
New
46
Increased
68
Reduced
48
Closed
44

Top Buys

Rank Stock Value
1
AIOS
AIOS Tech
AIOS
+$28.5M
2
AGMH icon
AGM Group Holdings
AGMH
+$13.2M
3
OG
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
+$7.66M
4
ESPR
Esperion Therapeutics
ESPR
+$7.53M
5
CNTX icon
Context Therapeutics
CNTX
+$6.14M

Top Sells

Rank Stock Value
1
ZNB
Zeta Network Group
ZNB
+$3.39M
2
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$3.33M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$3.06M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$2.84M
5
FLUX icon
Flux Power
FLUX
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 7.43%
2 Technology 5.89%
3 Financials 5.84%
4 Consumer Discretionary 1.07%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCVX icon
201
Vaxcyte
PCVX
$8.08B
– –
-66,483
Closed -$1.69M
PHIO icon
202
Phio Pharmaceuticals
PHIO
$12M
– –
-377
Closed -$83K
PHIO icon
203
PUT
Phio Pharmaceuticals
PHIO
$12M
– –
-13
Closed -$281K
PLUR icon
204
PUT
Pluri
PLUR
$16.8M
– –
-93
Closed -$197K
PRFX icon
205
PRF Technologies Ltd
PRFX
$3.13M
– –
-98
Closed -$326K
RCON icon
206
PUT
Recon Technology
RCON
$32.6M
– –
-63
Closed -$319K
LNAI
207
Lunai Bioworks
LNAI
$9.16M
– –
-991
Closed -$534K
SPY icon
208
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
– –
-444
Closed -$19.1M
STKH
209
Steakholder Foods
STKH
$1.67M
– –
-61
Closed -$443K
TRX icon
210
TRX Gold Corp
TRX
$266M
– –
-12,213
Closed -$6K
TRX icon
211
PUT
TRX Gold Corp
TRX
$266M
– –
-404
Closed -$20K
TTNP
212
PUT
DELISTED
Titan Pharmaceuticals
TTNP
– –
-9
Closed -$34K
XBI icon
213
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-3,500
Closed -$440K
IMG
214
DELISTED
CIMG Inc
IMG
– –
-713
Closed -$1.62M
NTBL
215
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-6
Closed -$41K
ASLN
216
PUT
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-8
Closed -$54K
DMK
217
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-43
Closed -$293K
MRTX
218
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-5,000
Closed -$776K
HCDIW
219
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
– –
-148,975
Closed -$83K
INFI
220
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
– –
-70,431
Closed -$177K
TCDA
221
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-475,000
Closed -$3.06M
EQOS
222
PUT
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
– –
-367
Closed -$119K
TRIL
223
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-120
Closed -$211K
TRIL
224
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-70,000
Closed -$1.23M
TRIL
225
PUT
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-1,109
Closed -$1.95M
6 7 8
9
10

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sabby Management held 231 positions worth $688M, down 7% from $740M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Sabby Management withdrew a net $219M in Q4 2021, closing 44 positions and reducing 48 holdings. Its most notable exit was Tricida, Inc. Common Stock, an estimated $3.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.4% of assets, up from 6.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in AIOS Tech worth $10.4M.

  • Sabby Management's largest Q4 2021 buy was AIOS Tech: 16,134 shares worth $10.4M.
  • Sabby Management added most to Acutus Medical Inc in Q4 2021, an estimated $3.52M increase.
  • Sabby Management's biggest Q4 2021 reduction was iPath Series B S&P 500 VIX Short-Term Futures ETN, cutting an estimated $3.33M.
  • Sabby Management fully exited Tricida, Inc. Common Stock in Q4 2021, selling an estimated $3.06M.
  • Sabby Management's ten largest holdings make up 66% of its $688M portfolio in Q4 2021.
  • Sabby Management opened 46 new positions and closed 44 in Q4 2021.
  • Sabby Management's portfolio value fell 7% quarter-over-quarter to $688M.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.